People: Koninklijke DSM NV (RDSMY.PK)
RDSMY.PK on OTC Markets Group
15.81USD
17 May 2013
15.81USD
17 May 2013
Price Change (% chg)
$0.09 (+0.57%)
$0.09 (+0.57%)
Prev Close
$15.72
$15.72
Open
$15.68
$15.68
Day's High
$15.84
$15.84
Day's Low
$15.67
$15.67
Volume
5,189
5,189
Avg. Vol
30,905
30,905
52-wk High
$16.34
$16.34
52-wk Low
$11.42
$11.42
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Robert Routs |
66 | 2011 | Chairman of the Supervisory Board |
Feike Sijbesma |
54 | 2007 | Chief Executive Officer and Chairman of the Managing Board |
Ewald Kist |
69 | 2008 | Deputy Chairman of the Supervisory Board |
Rolf-Dieter Schwalb |
61 | 2006 | Chief Financial Officer and Member of the Managing Board |
Chris Goppelsroeder |
54 | 2013 | Chief Executive Officer - Nutritional Products |
Philip Eykerman |
45 | 2011 | Executive Vice President Corporate Strategy & Acquisitions |
Heij Jos Op |
2012 | Senior Vice President Corporate Control and Accounting | |
Loek Radix |
Senior Vice President Corporate Control & Accounting | ||
Dave Huizing |
2012 | Vice President Investor Relations | |
Hans Vossen |
2012 | Vice President Corporate Treasury | |
Cees Los |
57 | 2012 | General Counsel and Director Legal Affairs |
Stefan Doboczky |
46 | 2011 | Member of the Managing Board |
Nico Gerardu |
62 | 2006 | Member of the Managing Board |
Stephan Tanda |
48 | 2007 | Member of the Managing Board |
Tom de Swaan |
67 | 2006 | Member of the Supervisory Board |
Victoria Haynes |
66 | 2012 | Member of the Supervisory Board |
Pierre Hochuli |
66 | 2005 | Member of the Supervisory Board |
Eileen Kennedy |
66 | 2012 | Member of the Supervisory Board |
Claudio Thomaz Lobo Sonder |
71 | 2005 | Member of the Supervisory Board |
Pauline van der Meer Mohr |
53 | 2011 | Member of the Supervisory Board |
Biographies
| Name | Description |
|---|---|
Robert Routs |
Mr. Robert (Rob) J. Routs has served as Chairman of the Supervisory Board of Koninklijke DSM NV since April 28, 2011. He was first appointed to the Supervisory Board, as Member, on March 31, 2010. He held various positions at Royal Dutch Shell before his retirement in 2008. He is currently Member of the Supervisory Board of Aegon NV, Royal KPN NV, Member of the Board of Directors of Aecom Technology Corporation, ATCO Group Ltd. and A.P. Moeller-Maersk Group. He is Member of the Company's Remuneration Committee and Chairman of the Company's Nominating Committee. |
Feike Sijbesma |
Mr. Feike Sijbesma has served as Chief Executive Officer and Chairman of the Managing Board of Koninklijke DSM NV (DSM) since May 1, 2007. He was first appointed as Member of the Managing Board in July 2000. He studied Medical Biology at the Universiteit Utrecht (University of Utrecht) and Business Administration at the Erasmus Universiteit Rotterdam (Erasmus University in Rotterdam). In 1987, he joined the Industrial Pharmaceuticals division of Gist-brocades, where was responsible for strategic planning and business development. From 1990 to 1993, he was appointed the division's Marketing and Sales Director. Thereafter he was given leadership of Savoury Ingredients and later on a business unit of Gist-brocades' Food Specialties Division. In 1995, he was made Director of that division and joined the Gist-brocades' Executive Committee. Following the acquisition by DSM in 1998 he became Director of the business group DSM Food Specialties. In 2000, Mr. Sijbesma joined DSM's Managing Board of Directors. He became Chairman of the Managing Board on May 1, 2007. In addition to this, Mr. Sijbesma also serves as Member of the Supervisory Board of De Nederlandsche Bank N.V. (Dutch Central Bank), Board Member of CEFIC (European Chemical Industry Council), Member of the Advisory Board of RSM Erasmus University and of ECP-EPN (Electronic Commerce Platform Netherlands). |
Ewald Kist |
Mr. Ewald Kist has served as Deputy Chairman of the Supervisory Board of Koninklijke DSM NV since March 26, 2008. He was first appointed as Member of the Supervisory Board in 2004. He is currently retired. The last position he held was Chairman of the Managing Board of the ING Group. Mr. Ewald also serves as Member of Supervisory Board at Royal Philips Electronics N.V., Stage Entertainment and Moody's Investor Services. He is Chairman of the Company's Remuneration Committee and Member of the Company's Nomination Committee. |
Rolf-Dieter Schwalb |
Mr. Rolf-Dieter Schwalb has served as Chief Financial Officer and Member of the Managing Board of Koninklijke DSM NV since October 1, 2006. He studied Mathematics and Business Administration at the Universitat Giessen (University of Giessen), Germany. In 1976 he joined Procter & Gamble GmbH Germany, where, over a period of 18 years, he held various positions in the IT and Finance disciplines, including that of Controller of Procter & Gamble GmbH Germany. In 1991 Mr. Schwalb joined the European Headquarters of Procter & Gamble in Brussels, Belgium, where he was responsible for the planning and controlling of all European activities. After a long career with Procter & Gamble, Mr. Schwalb joined Beiersdorf AG in Hamburg, Germany, in 1994. He took on the responsibility of Division Controller and later that of Manager Corporate Accounting/Controlling Beiersdorf AG. In October 2000 he was appointed CFO and Member of the Executive Board of Beiersdorf AG. |
Chris Goppelsroeder |
Mr. Chris Goppelsroeder is Chief Executive Officer - Nutritional Products of Koninklijke DSM NV effective January 1, 2013. He is Head of the Seed Care division of Syngenta. He was previously Member of the Managing Board. |
Philip Eykerman |
Mr. Philip Eykerman has served as Executive Vice President Corporate Strategy & Acquisitions of Koninklijke DSM NV effective December 31, 2011. He is currently Partner at McKinsey & Company, Brussels office. He joined McKinsey & Company in 1997 and is leader of McKinse's Chemicals Practice in the Benelux and France. He has been involved in a number of strategy development, transformation and mergers & acquisitions projects in the chemicals industry. |
Heij Jos Op |
Mr. Jos Op Heij has served as Senior Vice President Corporate Control and Accounting of Koninklijke DSM NV since August 1, 2012. Previously, he served as Vice President Corporate Treasury. He joined the Company in 1985. Mr. Heij holds a chartered controller degree. |
Loek Radix |
Mr. Loek Radix has served as Senior Vice President Corporate Control & Accounting of Koninklijke DSM NV. He joined the Company in 1988 and, after having held several positions in the business, he became the Corporate Controller of DSM. |
Dave Huizing |
Mr. Dave Huizing has served as Vice President Investor Relations of Koninklijke DSM NV since July 1, 2012. He started his career in DSM in 1985 as a lawyer. He held positions in Marketing & Sales and Key Account Management for DSM Materials businesses, before moving into general management positions, latterly at the Value Assurance Review team. |
Hans Vossen |
Mr. Hans Vossen has served as Vice President Corporate Treasury of Koninklijke DSM NV since August 1, 2012. Previously he served as Vice President Investor Relations. He started his career in EDP auditing at KPMG and joined DSM in 1991 as controller. After holding several positions in finance control and strategy, he joined Investor Relations in 2008. |
Cees Los |
Mr. Cees Los serves as General Counsel and Director Legal Affairs of Koninklijke DSM NV as of April 15, 2012. He has an international experience in Legal Affairs and has worked with several companies, including Shell. Most recently he was General Counsel with LyondellBasell Industries. |
Stefan Doboczky |
Mr. Stefan Doboczky has served as Member of the Managing Board of Koninklijke DSM NV (DSM) since May 2011. Prior to joining the Company in 1998, he worked for 6 years at ARCO Chemicals in Austria and the United Kingdom. At DSM, Mr. Doboczky started in the DSM Fine Chemicals division, where he became Business Manager. In 2002 he moved to DSM Pharma Chemicals where he was Business Director from 2003 till 2006 based in the Netherlands. In 2006, he became Vice President and Business Unit Director China for DSM Anti-Infectives based in China. Since 2009 he has been Business Group Director of DSM Anti-Infectives. Since becoming a Member of the Managing Board of Koninklijke DSM NV in May 2011 he has been responsible for DSM's global activities in Pharma, as well as all DSM's activities in Asia. He is also CEO of DSM Sinochem Pharmaceutical, a joint venture between DSM and Sinochem in the area of anti-infectives. Mr. Doboczky holds a Masters degree in Chemisty and a PhD degree in Natural and Technical Science from the University of Vienna and an MBA from IMD Business School in Lausanne, Switzerland. |
Nico Gerardu |
Mr. Nico H. Gerardu has been Member of the Managing Board of Koninklijke DSM NV (DSM) since April 1, 2006. He studied Chemistry at the Eindhoven University of Technology and Business Administration at Hasselt University (Belgium). He started his career with DSM in 1975 as Chemical Engineer in DSM's Engineering Department. He held a number of management positions in various parts of DSM (Stamicarbon, Plastic Products Division, Polymers Division and DSM Andeno). In 1996 he went to Linz as Business Unit Director DSM Chemie Linz, Austria. From 2000 till January 2006 he assumed the role of Business Group Director DSM Anti-Infectives in Delft, the Netherlands. In addition to this, he also serves as Member of the Supervisory Boards of Voestalpine Polynorm N.V., Bonnefanten Museum in Maastricht (Netherlands) and Board Member of VNCI (Association of the Dutch Chemical Industry). |
Stephan Tanda |
Mr. Stephan B. Tanda has served as Member of the Managing Board of Koninklijke DSM NV since May 1, 2007. He studied Polymer Engineering at the Montanuniversitaet Leoben (University of Leoben), Austria, and Business Administration at the Wharton Business School of the University of Pennsylvania. He started his career in 1991 as Business Segment Manager Europe - Nomex/Kevlar Protective Apparel with DuPont in Switzerland. After assignments in Finance and Operations with DuPont in the United States, he was appointed Global Business Director, based in Luxembourg. In 1998 Mr. Tanda became Director Corporate Planning and later Vice President Strategic Planning & New Business Development Agriculture, Nutrition and Bio-Based Materials for DuPont in the United States. In 2000 he was appointed President of Protein Technologies International, Inc. and later President and Chief Executive Officer of The Solae Company, United States, a Joint Venture between DuPont and Bunge in the area of food innovation and food ingredient manufacturing. In 2004 he was appointed President and Chief Executive Officer of Freudenberg Nonwovens, a global group of industrial businesses, based in Weinheim, Germany, and Durham, United States. In addition to this, Mr. Tanda also serves as Board Member of EuropaBio (European Biotechnology Industries Association), Board Member of scienceindustries (Swiss association for the chemical, pharmaceutical and biotech industries) and Board Member of Bio (US Biotechnology Industry Organization). |
Tom de Swaan |
Mr. Tom de Swaan has served as Member of the Supervisory Board of Koninklijke DSM NV since March 29, 2006. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial Officer/Chief Risk Officer ABN AMRO. Mr. de Swaan also serves as Non-Executive Director of the Board of GlaxoSmithKline Plc and of the Board of Zurich Financial Services, Chairman of the Supervisory Board of Van Lanschot Bankiers N.V., Vice Chairman of the Supervisory Board of Royal Ahold N.V., Board Member of Royal Concertgebouw Orchestra and Member of the Board of Trustees of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, as well as Chairman Advisory Board Rotterdam School of Management. Mr. de Swaan is Chairman of the Company's Audit Committee and Member of Remuneration Committee. |
Victoria Haynes |
Ms. Victoria F. Haynes has served as Member of the Supervisory Board of Koninklijke DSM NV since May 11, 2012. The last position she held was President and CEO of the Research Triangle Institute International. Currently she serves as Member of the Board of Directors of PPG, Nucor, Ziptronix and, as of 2013, Axiall. She is Member of the Company's Audit Committee. |
Pierre Hochuli |
Mr. Pierre Hochuli has served as Member of the Supervisory Board of Koninklijke DSM NV since April 6, 2005. He is former Chairman of the Board of Directors of Devgen N.V. and former Chairman of the Executive Committee, as well as former Member of the Board of Directors of Unibioscreen S.A. and former Member of the Board of Directors of Oncomethylome S.A. Mr. Hochuli also served as Venture Partner of Polytechnos Venture-Partners GmbH. He currently serves as Member of the Board of Directors of Domes of Silence Holdings Ltd. Mr. Hochuli is Member of the Company's Audit Committee and Corporate Social Responsibility Committee. |
Eileen Kennedy |
Ms. Eileen Kennedy has served as Member of the Supervisory Board of Koninklijke DSM NV since May 11, 2012. She is Professor of Nutrition Friedman School of Nutrition Science and Policy at Tufts University in Boston (United States). She is also Dean of Nutrition Friedman School of Nutrition Science and Policy at Tufts University in Boston, Global Executive Director of the International Life Sciences Institute, Washington D.C. (United States), Deputy Under Secretary for Research, Education and Economics at the United States Department of Agriculture. Ms. Kennedy is Member of the Company's Corporate Social Responsibility Committee. |
Claudio Thomaz Lobo Sonder |
Mr. Claudio Thomaz Lobo Sonder has served as Member of the Supervisory Board of Koninklijke DSM NV since April 6, 2005. He is currently retired. The last position he held was Chairman of the Managing Board of Celanese. Mr. Sonder also serves as Chairman of the Board of Lojas Renner S.A., Member of the Supervisory Boards of Companhia Suzano de Papel e Celulose S.A., RBS S.A. Media Group, Hospital Albert Einstein, OGX S.A. and as Executive Vice President of Suzano Holding S.A. Mr. Lobo Sonder is Member of the Company's Audit Committee. |
Pauline van der Meer Mohr |
Ms. Pauline F.M. van der Meer Mohr has served as Member of the Supervisory Board of Koninklijke DSM NV since April 28, 2011. She is currently President of the Executive Board of Erasmus University Rotterdam. Ms. van der Meer Mohr also serves as Member of the Supervisory Board of ASML N.V., Chair of the Supervisory Board of the Rotterdam School of Management, Member of the Supervisory Board of Nederlandse School voor Openbaar Bestuur, Director of the Hollandsche Maatschappij van Wetenschappen, Member of the Economic Development Board of Rotterdam and Member of the Duisenberg School of Finance Board. She is Chairman of Corporate Social Responsibility Committee. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Robert Routs |
78,185 |
Feike Sijbesma |
1,504,120 |
Ewald Kist |
63,538 |
Rolf-Dieter Schwalb |
748,227 |
Chris Goppelsroeder |
737,217 |
Philip Eykerman |
-- |
Heij Jos Op |
-- |
Loek Radix |
-- |
Dave Huizing |
-- |
Hans Vossen |
-- |
Cees Los |
-- |
Stefan Doboczky |
679,428 |
Nico Gerardu |
1,019,930 |
Stephan Tanda |
790,744 |
Tom de Swaan |
67,372 |
Victoria Haynes |
48,527 |
Pierre Hochuli |
61,151 |
Eileen Kennedy |
45,194 |
Claudio Thomaz Lobo Sonder |
67,151 |
Pauline van der Meer Mohr |
63,538 |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Robert Routs |
0 | 0 |
Feike Sijbesma |
0 | 0 |
Ewald Kist |
0 | 0 |
Rolf-Dieter Schwalb |
0 | 0 |
Chris Goppelsroeder |
0 | 0 |
Philip Eykerman |
0 | 0 |
Heij Jos Op |
0 | 0 |
Loek Radix |
0 | 0 |
Dave Huizing |
0 | 0 |
Hans Vossen |
0 | 0 |
Cees Los |
0 | 0 |
Stefan Doboczky |
0 | 0 |
Nico Gerardu |
0 | 0 |
Stephan Tanda |
0 | 0 |
Tom de Swaan |
0 | 0 |
Victoria Haynes |
0 | 0 |
Pierre Hochuli |
0 | 0 |
Eileen Kennedy |
0 | 0 |
Claudio Thomaz Lobo Sonder |
0 | 0 |
Pauline van der Meer Mohr |
0 | 0 |

